Lataa...
Immunotherapies in ovarian cancer
Ovarian cancer is the leading cause of death for gynaecological cancer, and new therapies are urgently awaited. Although the presence of tumour-infiltrating lymphocytes has been confirmed to be associated to a better prognosis, immunotherapy is not yet incorporated to the armamentarium in ovarian ca...
Tallennettuna:
| Julkaisussa: | EJC Suppl |
|---|---|
| Päätekijät: | , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Elsevier
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7573463/ https://ncbi.nlm.nih.gov/pubmed/33240447 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ejcsup.2020.02.002 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|